Ventyx shareholders re-elect two Class I directors, approve say-on-pay

Ventyx Biosciences, Inc.

Somasundaram Subramaniam re-elected: 17.2M for, 14.5M withheld, 18.0M broker non-votes.
Dr. Sheila Gujrathi re-elected: 29.4M for, 2.3M withheld, 18.0M broker non-votes.
Advisory say-on-pay approved: 20.4M for, 10.9M against, 0.37M abstain.
Ratification of Ernst & Young as auditor: 47.8M for, 1.6M against, 0.3M abstain.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.